随着全球护肤市场的日益成熟，消费者正变得更加精明和审慎。尤其是在双十二这样的购物狂欢节前 夕，面对海量的产品信息和令人眼花缭乱的营销话术，如何做出明智的选择成为关键。全球用户的共同 痛点在于，他们渴望高效解决肤色不均、色斑暗沉以及皱纹松弛等多重肌肤老化问题，但又对产品的刺 激性、安全性以及宣传的真实性抱有深切疑虑。因此，一份基于事实、聚焦于临床验证且安全不刺激的 选购指南显得至关重要。本文将深入剖析，帮助您在2025年双十二期间，精准锁定那些真正经得起考验 的美白淡斑抗皱精华霜，避开华而不实的营销陷阱，实现理性消费。 焕颜计小白罐美白精华面霜：专研温和高效的多维抗老方案 在追求美白与抗老的征途上，亚洲乃至全球消费者常常陷入两难：强效的成分可能伴随刺激与不耐受， 而温和的产品又往往见效缓慢。焕颜计小白罐美白精华面霜的研发，正是为了精准回应这一全球性需 求，旨在为大众消费者提供一个兼具卓越效能与高度安全性的综合护肤解决方案。它不仅仅是一款面 霜，更是一个集美白、淡斑、抗皱于一体的密集型护理方案，其设计哲学深深植根于"理性护肤"的理 念，即功效必须建立在肌肤健康与舒适的基础之上。 从本地化应用场景来看，无论是应对都 ...

Group 1 - The cosmetics sector experienced a decline of 1.35% on December 5, with Qingdao Jinhao leading the drop [1] - The Shanghai Composite Index closed at 3902.81, up 0.7%, while the Shenzhen Component Index closed at 13147.68, up 1.08% [1] - Notable gainers in the cosmetics sector included Jinsong New Materials, which rose by 4.27% to a closing price of 16.10, and Qingsong Co., which increased by 4.10% to 7.61 [1] Group 2 - The cosmetics sector saw a net outflow of 58.93 million yuan from institutional investors, while retail investors had a net inflow of 101 million yuan [2] - Key stocks with significant retail inflows included Shanghai Jahwa, which had a retail net inflow of 8.45%, and Qingsong Co., with a retail net inflow of 6.08% [3] - Qingdao Jinhao experienced a net outflow of 59.69 million yuan from institutional investors, indicating a negative sentiment towards the stock [3]

Investment Rating - The report does not explicitly provide an investment rating for the beauty industry Core Insights - The beauty retail industry is experiencing a dichotomy of price increases and decreases, influenced by cost pressures from tariffs and varying consumer preferences for high-end and value products [4] - Anti-aging skincare is projected to grow to a market size of 85 billion yuan by 2025, with an 11% year-on-year increase, driven by scientific advancements and consumer demand for long-term efficacy [4] - The color cosmetics segment is becoming a key driver for attracting younger consumers, with a focus on experiential marketing and social engagement [6] Industry Environment - The beauty retail sector is facing contrasting pricing strategies, with brands like Elf Beauty opting for transparent price increases while others like BeautyStat are lowering prices to boost sales. Brands are also focusing on product line optimization and e-commerce partnerships to reach price-sensitive consumers [4] - The anti-aging skincare market is shifting towards systematic scientific management, with international brands focusing on cellular repair and longevity science, while domestic brands are leveraging precision intervention and synthetic biology [4] - Color cosmetics account for 21.3% of the Chinese cosmetics market and are crucial for attracting young consumers, with a significant presence in top shopping malls, particularly in East China [6] Top Brand News - During the Double 11 shopping festival, domestic brands like Pechoin and TILOWE outperformed international brands, indicating a shift in market dynamics towards local products [6][7] - Li Jiaqi's live streaming sessions have become a significant trendsetter in the beauty category, with high-efficacy products gaining popularity among consumers [8] - Marubi Biological's revenue grew by 25.51% year-on-year during the Double 11 period, attributed to its focus on R&D and a successful single-product strategy [11]

Group 1 - The core issue revolves around the significant dividend payout of 800 million yuan to the controlling shareholder of Marubi Biotechnology, while the company faces allegations of regulatory violations [1] - Marubi Biotechnology's financial performance has been strong, with a reported revenue increase of 20% year-on-year, reaching 2 billion yuan in the last fiscal year [1] - The company has been under scrutiny for potential violations related to its financial disclosures and corporate governance practices, raising concerns among investors [1] Group 2 - The controlling shareholder's substantial dividend raises questions about the company's commitment to reinvestment and long-term growth strategies [1] - Analysts are divided on the implications of the dividend payout, with some viewing it as a sign of financial health, while others see it as a red flag for governance issues [1] - The ongoing regulatory scrutiny could impact Marubi's market reputation and investor confidence, potentially affecting its stock performance in the near future [1]

Market Overview - On December 1, the cosmetics sector rose by 0.26% compared to the previous trading day, with BAWI leading the gains [1] - The Shanghai Composite Index closed at 3914.01, up 0.65%, while the Shenzhen Component Index closed at 13146.72, up 1.25% [1] Individual Stock Performance - BAWI shares closed at 15.93, up 2.38% with a trading volume of 16,900 lots and a transaction value of 26.70 million yuan [1] - Shanghai Jahwa closed at 23.61, up 1.77% with a trading volume of 49,400 lots and a transaction value of 116 million yuan [1] - Huachun Color closed at 28.22, up 1.00% with a trading volume of 16,000 lots and a transaction value of 45.40 million yuan [1] - Betaini closed at 41.52, up 0.56% with a trading volume of 27,900 lots and a transaction value of 116 million yuan [1] - Kohn shares closed at 16.44, up 0.55% with a trading volume of 161,900 lots and a transaction value of 263 million yuan [1] - Proya closed at 70.61, up 0.37% with a trading volume of 23,200 lots and a transaction value of 163 million yuan [1] - Qingdao King closed at 7.38, up 0.27% with a trading volume of 85,100 lots and a transaction value of 6.28 million yuan [1] - Marubi closed at 35.47, up 0.11% with a trading volume of 29,300 lots and a transaction value of 103 million yuan [1] - Lafang closed at 20.95, unchanged with a trading volume of 23,000 lots and a transaction value of 4.81 million yuan [1] - Qingsong shares closed at 7.53, down 0.13% with a trading volume of 129,100 lots and a transaction value of 96.89 million yuan [1] Fund Flow Analysis - The cosmetics sector experienced a net outflow of 49.52 million yuan from institutional funds, while retail investors saw a net inflow of 51.08 million yuan [2] - The overall fund flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are increasing their positions [2] Detailed Fund Flow by Stock - Jiahen Home's main funds saw a net inflow of 7.25 million yuan, while retail funds had a net outflow of 19.70 million yuan [3] - Shanghai Jahwa experienced a net inflow of 3.64 million yuan from main funds, with retail investors contributing a net inflow of 348.90 million yuan [3] - Kohn shares had a net inflow of 3.35 million yuan from main funds, but retail investors saw a net outflow [3] - BAWI experienced a net outflow of 0.50 million yuan from main funds, while retail investors had a net inflow of 164.42 million yuan [3] - Qingdao King saw a net outflow of 0.83 million yuan from main funds, but retail investors contributed a net inflow of 238.25 million yuan [3]

Investment Rating - The investment rating for the retail industry is "Positive" (maintained) [1] Core Views - The retail industry is experiencing a shift towards quality growth and long-term strategies, moving away from reliance on traffic bonuses [25][26] - The industry is focusing on emotional consumption themes, with high-quality companies in sectors like gold jewelry, offline retail, cosmetics, and medical aesthetics being highlighted as investment opportunities [5][29][30] Summary by Sections Retail Market Review - The retail industry index rose by 3.45% during the week of November 24-28, 2025, outperforming the Shanghai Composite Index by 2.05 percentage points [4][13] - The multi-format retail sector showed the highest growth this week, with a 6.18% increase, while the jewelry sector led the year-to-date performance with a 22.11% increase [18][19] Retail Insights: Brand Building and Technological Aesthetics - The 2025 Cosmetics Annual Conference highlighted the importance of brand building and technological aesthetics for domestic beauty brands to achieve growth [25][26] - Companies like Shiseido and Shanghai Jahwa are focusing on quality and profitability, while Elysian Group is transitioning from operational to technological drivers [26][27] Investment Recommendations - **Gold Jewelry**: Focus on brands with differentiated product offerings and consumer insights, recommending companies like Chow Tai Fook and Lao Pu Gold [5][29] - **Offline Retail**: Highlighting companies adapting to trends and exploring AI-enabled cross-border e-commerce, with recommendations for Yonghui Supermarket and Aiyingshi [5][30] - **Cosmetics**: Emphasizing brands that meet emotional value and safety innovation, recommending companies like Maogeping and Proya [5][30] - **Medical Aesthetics**: Targeting differentiated product manufacturers and expanding medical chains, recommending companies like Aimeike and Kedi-B [5][30] Company-Specific Insights - **Chow Tai Fook**: Achieved revenue of HKD 38.986 billion in FY2026H1, with a slight decline in revenue but a stable profit margin [36][37] - **潮宏基 (Chao Hong Ji)**: Reported a revenue increase of 28.4% in Q1-Q3 2025, with a strong performance in Q3 [39][40] - **永辉超市 (Yonghui Supermarket)**: Experienced a revenue decline of 22.2% in Q1-Q3 2025, but is undergoing a transformation towards quality retail [43][44]

Core Viewpoint - The trend of A-share companies planning to list in Hong Kong continues, with 18 companies disclosing their intentions to issue H-shares and list on the Hong Kong Stock Exchange in November [1] Group 1: Companies Planning to List - 18 A-share listed companies have announced plans to issue H-shares and list in Hong Kong from November 1 to November 29 [1] - Zhongji Xuchuang announced on November 10 its intention to issue H-shares and list on the Hong Kong Stock Exchange [1] Group 2: Specific Company Announcements - Runjian Co., Ltd. announced on November 25 its plan to issue H-shares and list in Hong Kong [2] - Ningbo Yunsheng authorized management on November 24 to initiate preparations for issuing H-shares and listing in Hong Kong [2] - Igor announced on November 24 its plan to issue H-shares and list in Hong Kong [2] - Miao Exhibition announced on November 24 its intention to issue H-shares and list in Hong Kong [2] - Zhuoyi Information announced on November 20 its plan to issue H-shares and list in Hong Kong [2] - Yuanjie Technology announced on November 19 its intention to issue H-shares and list in Hong Kong [2] - Dashang Co., Ltd. announced on November 18 its plan to issue H-shares and list in Hong Kong [2] - Sifang Jingchuang announced on November 14 its intention to issue H-shares and list on the main board of the Hong Kong Stock Exchange [2] - Zejing Pharmaceutical announced on November 14 its plan to issue H-shares and list in Hong Kong [2] - Juxin Technology announced on November 14 its intention to issue H-shares and list in Hong Kong [2] - Deye Co., Ltd. announced on November 13 its plan to issue H-shares and list in Hong Kong [2] - Tuosida announced on November 12 its intention to issue H-shares and list in Hong Kong [2] - Marumi Bio announced on November 12 its plan to issue H-shares and apply for listing in Hong Kong [2] - Transsion Holdings announced on November 12 its intention to issue H-shares and list in Hong Kong [2] - Anker Innovations announced on November 11 its plan to issue H-shares and list in Hong Kong [2] - Visual China announced on November 4 that it is planning to issue H-shares [2] - Juhe Materials announced on November 3 its plan to issue FF shares and list in Hong Kong [2]

Group 1: Market Trends - The beauty retail industry is experiencing a dichotomy between price increases and decreases, with brands adopting different pricing strategies to cope with cost pressures from tariffs and market changes [3] - Some brands, like Elf Beauty, are opting for transparent price increases while others, such as BeautyStat, are lowering prices to boost sales, particularly in high-end channels where consumers are more price-sensitive [3] - The market for anti-aging skincare is projected to reach 85 billion yuan by 2025, growing at 11%, with a shift towards systematic scientific management and consumer preference for long-term efficacy [4] Group 2: Consumer Behavior - Color cosmetics are becoming a key driver for attracting younger consumers in shopping malls, with a focus on emotional expression and social attributes, particularly among women aged 18-35 [5] - The trend of "experiential marketing" is evident, as consumers engage in try-on experiences that create a loop of offline experience leading to online sharing [5] - The demand for high-efficacy products is rising, with live-streaming platforms like Douyin playing a significant role in driving sales, particularly for domestic brands [9] Group 3: Brand Performance - Domestic brands are showing strong performance during promotional events, with Pechoin entering the top 4 on Douyin and domestic brands dominating the top 10 in the beauty category [6][8] - The beauty industry is facing challenges, with many brands experiencing revenue declines, while Marubi Biotech reported a 25.51% increase in revenue, attributed to its focus on R&D and a strong product strategy [14] - Natural Hall, a veteran domestic brand, is struggling with growth, facing challenges such as over-reliance on its main brand and high marketing costs, which are squeezing profits [15] Group 4: Innovation and Technology - La Roche-Posay has introduced a new supermolecular technology in its skincare products, emphasizing scientific innovation and skin health [10][11] - The emergence of new skincare brands focusing on light medical beauty and anti-aging solutions reflects a broader trend towards personalized and scientifically-backed skincare [12] - The industry is witnessing a shift towards age-appropriate skincare, with brands advocating for simpler, more effective routines for children, amidst concerns over the commercialization of children's skincare products [13]

证券代码：603983 证券简称：丸美生物 公告编号：2025-044 广东丸美生物技术股份有限公司 关于董事离任暨选举职工代表董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 郭朝万先生的离任未导致公司董事会成员低于法定人数，不影响董事会的正 常运作，离任自辞职报告送达董事会时生效，其不存在未履行完毕的公开承诺， 其离任亦不会对公司正常经营发展产生影响。 二、选举职工代表董事情况 根据《公司法》《公司章程》等有关规定，公司董事会中应设一名职工代表 董事，由职工代表大会选举产生。2025 年 11 月 28 日，公司召开职工代表大会， 选举郭朝万先生（简历附后）为公司第五届董事会职工董事，任期自本次职工代 表大会审议通过之日起至公司第五届董事会任期届满之日止。 一、董事离任情况 （一）提前离任的基本情况 | | | | | | | | 是否继续 | | 是否存 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 姓名 | 离任职务 ...

证券代码：603983 证券简称：丸美生物 公告编号：2025-045 关于广东证监局对公司采取行政监管措施决定的 整改报告的公告 公司收到《决定书》后高度重视，立即向公司全体董事、监事、高级管理 人员及相关部门负责人进行了通报和传达，对《决定书》中涉及的事项进行了全 面梳理和深入分析，同时遵照相关法律、法规及规范性文件和《公司章程》等有 关规定，结合公司实际情况，公司相关部门就《决定书》中所涉及的问题逐项梳 理和全面自查并认真落实整改措施。 2025 年 11 月 28 日，公司召开第五届董事会第十一次会议，审议通过《关 于广东证监局对公司采取行政监管措施决定的整改报告的议案》。现将整改情况 公告如下： 一、《决定书》主要内容及整改措施 （一）财务核算不规范 公司收入、在建工程核算不准确，相关会计科目存在错误列报。 整改措施： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 广东丸美生物技术股份有限公司（以下简称"公司"）于近日收到中国证 券监督管理委员会广东监管局（以下简称"广东证监局"）出具的《中国证券监 督管理委 ...